Q4 2016 Holdings
Filed 2017-02-14 | 7 holdings | $704.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-05-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | Common | 00287Y109 | $703.4M | 11,232,758 | 99.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $507.2K | 10,310,511 | 0.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $414.1K | 7,451,128 | 0.1% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $335.0K | 10,507,608 | 0.0% |
| Biogen Inc(BIIB) | Common | 09062X103 | $64.9K | 248,530 | 0.0% |
| Gilead Sciences Inc(GILD) | Common | 375558103 | $44.0K | 614,300 | 0.0% |
| Northwest Biotherapeutics Inc(NWBO) | Common | 66737P600 | $8.6K | 24,815,028 | 0.0% |